Elodie Amar-Bouaziz

Paris, 75010, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Plasma and CSF adiponectin levels in biomarker-confirmed Alzheimer's disease: A cross-sectional study in a tertiary memory clinic.

Plasma and CSF adiponectin levels in biomarker-confirmed Alzheimer's disease: A cross-sectional study in a tertiary memory clinic.

Journal: Metabolic brain disease

Published: May 14, 2026

Eligibility for lecanemab treatment in a French memory clinic setting.

Eligibility for lecanemab treatment in a French memory clinic setting.

Journal: Journal of neurology

Published: January 09, 2026

Longitudinal Study of Plasma NFL and GFAP as Biomarkers of Alcohol Withdrawal-Associated Brain Injury.

Longitudinal Study of Plasma NFL and GFAP as Biomarkers of Alcohol Withdrawal-Associated Brain Injury.

Journal: Addiction biology

Published: December 31, 2025

Assessment of medication-related risks for mortality prediction in Alzheimer's disease.

Assessment of medication-related risks for mortality prediction in Alzheimer's disease.

Journal: Maturitas

Published: December 04, 2025

Association of Alzheimer's disease biomarkers with malnutrition and altered body composition in cognitively impaired patients: a cross-sectional memory clinic study.

Association of Alzheimer's disease biomarkers with malnutrition and altered body composition in cognitively impaired patients: a cross-sectional memory clinic study.

Journal: Alzheimer's research & therapy

Published: October 29, 2025

Cerebrospinal fluid acetylcholine is not a reliable diagnostic marker for Alzheimer's disease and dementia with Lewy bodies.

Cerebrospinal fluid acetylcholine is not a reliable diagnostic marker for Alzheimer's disease and dementia with Lewy bodies.

Journal: Journal of Alzheimer's disease : JAD

Published: October 22, 2025

Dual risk of anticholinergic burden and CSF alzheimer's biomarkers in older patients: a mortality follow-up study from daily medical practice.

Dual risk of anticholinergic burden and CSF alzheimer's biomarkers in older patients: a mortality follow-up study from daily medical practice.

Journal: Alzheimer's research & therapy

Published: May 15, 2025

Cerebrospinal fluid leptin in Alzheimer's disease: relationship to plasma levels and to cerebrospinal amyloid.

Cerebrospinal fluid leptin in Alzheimer's disease: relationship to plasma levels and to cerebrospinal amyloid.

Journal: Clinical chemistry and laboratory medicine

Published: March 13, 2025

Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview.

Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 10, 2025

Revisiting ABCB1 polymorphism: a missing piece in Alzheimer's risk and treatment?

Revisiting ABCB1 polymorphism: a missing piece in Alzheimer's risk and treatment?

Journal: Journal of translational medicine

Published: February 15, 2025

Usefulness of Cerebrospinal Fluid Alzheimer's disease biomarkers in older patients: Evidence from a national multicenter prospective study.

Usefulness of Cerebrospinal Fluid Alzheimer's disease biomarkers in older patients: Evidence from a national multicenter prospective study.

Journal: The journal of prevention of Alzheimer's disease

Published: January 12, 2025

Unraveling Homocysteine's Role in Dementia: No Specific Association with Alzheimer's Disease, but a Connection to White Matter Hyperintensities.

Unraveling Homocysteine's Role in Dementia: No Specific Association with Alzheimer's Disease, but a Connection to White Matter Hyperintensities.

Journal: Aging and disease

Published: January 06, 2025

Showing 1-12 of 58

Last Updated: 09/26/2026